Yu-Kyeong Hwang
Direttore/Membro del Consiglio presso GC CELL CORPORATION
Profilo
Yu-Kyeong Hwang is currently the Director, Senior MD & Head-Research Institute at GC Cell Corp.
Prior to this, Dr. Hwang worked as a Director at GREEN CROSS CELL Corp.
and as a Director at Artiva Biotherapeutics, Inc. from 2019 to 2022.
Dr. Hwang completed their undergraduate degree at Indiana University.
Posizioni attive di Yu-Kyeong Hwang
| Società | Posizione | Inizio |
|---|---|---|
| GC CELL CORPORATION | Direttore/Membro del Consiglio | 01/09/2014 |
Precedenti posizioni note di Yu-Kyeong Hwang
| Società | Posizione | Fine |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/04/2022 |
| GREEN CROSS CELL CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Yu-Kyeong Hwang
| Indiana University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GC CELL CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
GREEN CROSS CELL Corp.
 GREEN CROSS CELL Corp. BiotechnologyHealth Technology GREEN CROSS CELL Corp. engages in the provision of anti-cancer immunotherapy. It operates through the following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation, and Other Services. The company was founded on September 17, 1992 and is headquartered in Yongin-si, South Korea. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Yu-Kyeong Hwang
